NCT02494882
- Conditions
- Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,031 public trials
2,028 recruiting studies
Lymphoproliferative Disorders trial results
Active, Not Recruiting
A Phase II Study Using Rituximab Plus Venetoclax in the Front Line Treatment of Marginal Zone Lymphoma
NCT04416451
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- City of Hope Cancer Center (Data collection only) Duarte, California, United States
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (All protocol activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (All protocol Activities) Montvale, New Jersey, United States
NCT04181827
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Mayo Clinic Cancer Center-Scottsdale Phoenix, Arizona, United States
- Stanford University Medical Center Stanford, California, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
Active, Not Recruiting
A Study of JNJ-87562761 in Participants With Relapsed or Refractory Multiple Myeloma
NCT06604715
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- Princess Margaret Hospital Toronto, Ontario, Canada
- Jewish General Hospital Montreal, Quebec, Canada
- Seoul National University Hospital Seoul, South Korea
- Asan Medical Center Seoul, South Korea
Active, Not Recruiting
A Study of Talquetamab With Other Anticancer Therapies in Participants With Multiple Myeloma
NCT05050097
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- University of Alabama Birmingham Birmingham, Alabama, United States
- University of California San Francisco San Francisco, California, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
- Emory University Atlanta, Georgia, United States
Active, Not Recruiting
An Open-Label Phase lB/II Study of Glofitamab and Atezolizumab or Polatuzumab Vedotin in Adult Patients With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma
NCT03533283
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- UZ Gent Ghent, Belgium
- Aarhus Universitetshospital Skejby Aarhus N, Denmark
- Rigshospitalet København Ø, Denmark
- Odense Universitetshospital Odense C, Denmark
NCT04923893
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- UCSF San Francisco, California, United States
- Yale Cancer Center New Haven, Connecticut, United States
- University of Miami Health System Miami, Florida, United States
- AdventHealth Cancer Institute Orlando, Florida, United States
Active, Not Recruiting
A Study of Ciltacabtagene Autoleucel and Talquetamab for the Treatment of Participants With High-Risk Multiple Myeloma
NCT06550895
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- University of Iowa Hospital and Clinics Iowa City, Iowa, United States
- Norton Cancer Institute Louisville, Kentucky, United States
- Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
- Icahn School of Medicine at Mount Sinai New York, United States
Active, Not Recruiting
Study to Compare the Effectiveness and Safety of Golcadomide Plus R-CHOP vs Placebo Plus R-CHOP in Participants With Previously Untreated High-risk Large B-cell Lymphoma
NCT06356129
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- Local Institution - 0014 Mobile, Alabama, United States
- Local Institution - 0477 Anchorage, Alaska, United States
- Local Institution - 0452 Phoenix, Arizona, United States
- Local Institution - 0342 San Francisco, California, United States
NCT03462719
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
- Locations
-
- Norton Cancer Institute Louisville, Kentucky, United States
- John Theurer Cancer Center Hackensack, New Jersey, United States
- Novant Health Charlotte, North Carolina, United States
- Institut - Jules Bordet Anderlecht, Belgium